Initial concentration-time profile of gentamicin determines efficacy against Enterobacter cloacae ATCC 13047

In vitro studies were designed to investigate the influence of peak drug concentration (C-max), the area under the concentration-time curve (AUC), and, consequently, the trough concentration on the bactericidal effects of gentamicin against Enterobacter cloacae (MIC, 0.5 mg/liter) by simulating bolus versus infusion administration and bolus dosing with altered drug clearance. Bacteria in the lag phase were exposed to gentamicin concentration-time profiles modelling either bolus or infusion dosing (AUC constant, C-max changing) with 30-min postdose peak concentrations (C-peak30) of 4, 6, 8, and 10 mg/liter or bolus dosing with normal and double drug clearance (C-max constant, AUC changing) corresponding to normal clearance profiles with C-peak30 of 6 and 8 mg/liter, Exposure to gentamicin caused early bactericidal effects apparent by 2 h, followed by variable bacteriostatic and recovery phases. Exposure to bolus profiles resulted in greater bactericidal activity than the corresponding infusion profile up to a C-peak30 of 8 mg/liter. At a C-peak30 of 10 mg/liter, there were no differences in bactericidal effect. Double clearance profiles had a reduced bactericidal effect at 6 mg/liter compared to the corresponding normal clearance profile, but no differences in bactericidal effect were observed for 8-mg/liter double and normal clearance profiles. These results suggest that the initial exposure (i,e,, 0 to 30 min) Is a more important determinant for bacterial killing than the AUC or trough concentration for this bacterium, Subject to confirmation of these findings with other gram-negative bacteria, to optimize aminoglycoside efficacy the initial exposure (C-max) should be maximized by giving higher doses or bolus administration at intervals which may not produce detectable trough concentrations. Clinical trials with a broad range of patients, especially those with higher clearance, would confirm these in vitro observations and define optimal dosing recommendations.